TVP-1012
Drug timelines are a Plus or Pro feature.
5 regulatory and trial events tracked for TVP-1012, covering 2012-10-18 to 2019-04-19. Get the full timeline:
Most recent: Clinical Trial Update: A Long-term, Phase 3 Study of TVP-1012 (1 mg) in Levodopa Treated Parkinson's Disease Participants [Phase 3]